pat_cret, then step up to the plate.
Mule,Elan pharmaceutical business will have revenues of over 1 B $ in 2002.Growth rate of the 10 top US products = 70 % in the 1rst quarter.Europe growing by 25 - 30 % a year.Without even taking in account their other businesses, just the value of their pharmaceutical business would warrant a much higher price for Eln.
Mule,Thanks for your kind words yesterday...I was laughing alone today, remembering your thoughts about classic value and cigar-butts investing, and keeping in mind the price of Eln. I was almost sure you were at work on this one...I'll post shortly some thoughts on this topic
I step up, personnally. 80 % more shares at 2.48.
Pat,Just curious as to what your cost basis is now?